Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 20 for “"Shock and kill"”.
-
THE LATENT RESERVOIR IN ELITE CONTROLLERS AND FACTORS THAT AFFECT THE SUPPRESSIVE CAPACITIES OF IMMUNE EFFECTOR CELLS IN HIV POSITIVE INDIVIDUALS
Our inability to efficiently target and eliminate the latent reservoir remains the biggest barrier to a cure to HIV/AIDS. Accordingly, there exist several ongoing efforts to not only understand the reservoir in varied patient groups, but also to determine an efficient means to achieve either a …
-
The impact of heptose phosphates on HIV latency and human immune responses
… agents (ARTs) achieves total control of viremia and prevents progression of HIV to AIDS, but they are not a cure. Shock-and-kill therapy aims to use HIV latency reversal agents to promote clearance of HIV infected CD4 T-cells that make up the HIV reservoir to achieve drug-free remission from HIV. …
-
INVESTIGATING HIV-1 LATENCY REVERSAL UPON COGNATE ANTIGEN RECOGNITION IN CD4+ T CELLS FROM PEOPLE ON ANTIRETROVIRAL THERAPY
… which effectively prevents viral replication and transmission, there is no cure for Human Immunodeficiency Virus type 1 (HIV-1) infection. Treatment for most persons with HIV-1 (PWH) requires lifelong adherence to ART, as its cessation results in viral rebound within weeks. Viral rebound is …
-
Cell intrinsic innate immunity protein RPRD2 restricts transcription from the HIV-1 LTR in human cell lines
… therapy is never curative. The establishment and persistence of latency are complex and still incompletely characterised. Host factors that repress retroviral transcription are thought to be involved in this phenomenon. RPRD2 was identified as an antiviral protein that restricts HIV …
-
Mechanistic approaches for reactivation and elimination of latent HIV-1
… expression maintains this barrier to a cure. Shock-and-kill, a prominent strategy for HIV-1 eradication, requires the reactivation of latent HIV-1 gene expression. Global T cell activation is a well-characterized means of inducing HIV-1 transcription, but is considered too toxic for clinical …
-
Development of the Molecular Biology of HIV-Seek: A Novel Approach to Characterizing Latently Infected CD4+ T Cells
… (ART) is effective at managing HIV infection and extending the lives of people living with HIV (PLWH), it is limited by the inability to target the HIV viral reservoir, specifically in latently infected CD4+ T cells. Strategies for targeting the viral reservoir, including “shock and kill” and …
-
Development of Microfluidics for Use in a Novel Way to Characterize Latently HIV-Infected Cells
… considered for eradicating latent HIV such as “shock and kill” and “block and lock”but are still in development and have shown poor results in clinical trials thus far. Laboratory techniques such as STIP-Seq and HIV-Flow have been developed to quantify and characterize the HIV reservoir but do …
-
Role of the Tigit Immune Checkpoint Pathway in the Eradication of HIV Infection
… contributes substantially to global morbidity and mortality, with no immediate promise of an effective vaccine or cure. One major obstacle to vaccine development and therapy is to understand why HIV replication persists in a person despite the presence of viral specific immune responses. The …
-
Generation of an HIV-inducible intron expression cassette as a novel AAV-based therapy against latent HIV infection
… cells persist until cART lose effectiveness and symptoms arise again. A therapeutic approach able to eradicate chronically infected cells would then be desirable to cure – rather than restrain – HIV infection.<br/><br/>The focus of this work was therefore to evaluate whether a novel …
-
DESIGN AND DEVELOPMENT OF BISPECIFIC ANTIBODIES FOR HIV-1 RESERVOIR ELIMINATION
… human immunodeficiency virus type 1 (HIV-1), and despite advances in HIV-1 prevention, there are still 1.5 million new cases annually. Although antiretroviral therapy (ART) regimens suppress viral replication and prevent immunodeficiency, ART is not curative and cessation of treatment results …
-
T Cell Effector Responses in HIV-1 Cure Strategies
… over 35 million individuals around the world, and yet despite present treatments, there remains a need for a cure. A current cure tactic widely researched is the “shock and kill” strategy, where cART-treated HIV-positive individuals would be given latency reactivating agents (LRAs) to induce …
-
Characterization and exploitation of host factors to modulate HIV-1 latency
… viral replication. However, ART is not a cure and must be administered life-long with discontinuation resulting in viral rebound. The persistence of HIV-1 is the result of a fraction of provirus establishing latency early upon infection of T cells. This population of transcriptionally silent …
-
Small molecules effective for disruption of HIV-1 latency
… of the disease. This thesis focuses on the shock phase of a proposed cure strategy known as “shock and kill,” which aims to induce latent HIV-1 reservoirs that could then be purged via a boosted immune response, specific targeting of infected cells, or by viral-induced apoptosis. …
-
Strategies to Facilitate the Eradication of the HIV-1 Reservoir
… Virus type 1 (HIV-1) infection globally and more than 70 million deaths can be attributed to the pathogen so far. HIV-1 primarily infects CD4 T cells leading to their widespread destruction that eventually manifests as Acquired Immunodeficiency Syndrome (AIDS), characterized by …
-
A CRISPR Screen of HIV Dependency Factors to Identify Host Proteins Necessary for Activation of Latent HIV Proviruses
… virus (HIV) integrates into host DNA and therefore persists as a long-lived pathogen in people living with HIV (PLHIV). One of the greatest challenges to achieving a cure for human immunodeficiency virus (HIV) is the presence of latently infected long-lived immune cells that endure …
-
A CRISPR-screening approach to increase HIV latency reversal to improve an HIV cure strategy
… is currently no way to eradicate the long-lived and stable HIV reservoir that evades the immune system but retains the ability to reactivate and spread virus. Understanding mechanisms that govern HIV latency within these reservoirs, such as host and viral factors that influence transcription …
-
Pharmacologic Stratagies Toward Curing HIV-1 Infection: Identification and Evaluation of Small-Molecule HIV-1 Latency Reversing Agents
… pharmacologic induction of HIV-1 transcription and subsequent killing of infected cells by cytolytic T lymphocytes (CTLs) or viral cytopathic effects. Initial strategies to reactivate latent HIV-1 through nonspecific global T cell activation proved to have unacceptable toxicity, precluding its …
-
On the Origin of AIDS: CARD8’s Role in Pathogenesis and Cure
… health burden with 1.7 million new acquisitions and 770,000 deaths in 2018 alone. While these numbers are declining due to antiretroviral therapy, only a handful of individuals have achieved complete remission from HIV. With the advent of antiretroviral therapy, HIV has turned a death sentence …
-
Opioid use disorder suppresses HIV-1 latent reactivation in people with HIV and a strategy for permanent repression of HIV-1 expression
… opioid use affects the host immune system and increases an individual’s susceptibility to HIV infection. However, it is unclear how opioid use changes the course of HIV pathogenesis. Particularly, there is a gap in understanding how opioids impact HIV latency. Latency results in a reservoir …